Cargando…

The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes

AIMS/HYPOTHESIS: We examined the hypothesis that elevation in urinary albumin creatinine ratio (ACR) in adolescents with type 1 diabetes is associated with abnormal retinal vascular geometry (RVG) phenotypes. METHODS: A cross-sectional study at baseline of the relationship between ACR within the nor...

Descripción completa

Detalles Bibliográficos
Autores principales: Benitez-Aguirre, Paul Z., Wong, Tien Y., Craig, Maria E., Davis, Elizabeth A., Cotterill, Andrew, Couper, Jennifer J., Cameron, Fergus J., Mahmud, Farid H., Jones, Tim W., Hodgson, Lauren A. B., Dalton, R. Neil, Dunger, David B., Donaghue, Kim C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447498/
https://www.ncbi.nlm.nih.gov/pubmed/29396691
http://dx.doi.org/10.1007/s00125-017-4538-2
_version_ 1783408504171659264
author Benitez-Aguirre, Paul Z.
Wong, Tien Y.
Craig, Maria E.
Davis, Elizabeth A.
Cotterill, Andrew
Couper, Jennifer J.
Cameron, Fergus J.
Mahmud, Farid H.
Jones, Tim W.
Hodgson, Lauren A. B.
Dalton, R. Neil
Dunger, David B.
Donaghue, Kim C.
author_facet Benitez-Aguirre, Paul Z.
Wong, Tien Y.
Craig, Maria E.
Davis, Elizabeth A.
Cotterill, Andrew
Couper, Jennifer J.
Cameron, Fergus J.
Mahmud, Farid H.
Jones, Tim W.
Hodgson, Lauren A. B.
Dalton, R. Neil
Dunger, David B.
Donaghue, Kim C.
author_sort Benitez-Aguirre, Paul Z.
collection PubMed
description AIMS/HYPOTHESIS: We examined the hypothesis that elevation in urinary albumin creatinine ratio (ACR) in adolescents with type 1 diabetes is associated with abnormal retinal vascular geometry (RVG) phenotypes. METHODS: A cross-sectional study at baseline of the relationship between ACR within the normoalbuminuric range and RVG in 963 adolescents aged 14.4 ± 1.6 years with type 1 diabetes (median duration 6.5 years) screened for participation in AdDIT. A validated algorithm was used to categorise log(10) ACR into tertiles: upper tertile ACR was defined as ‘high-risk’ for future albuminuria and the lower two tertiles were deemed ‘low-risk’. RVG analysis, using a semi-automated computer program, determined retinal vascular calibres (standard and extended zones) and tortuosity. RVG measures were analysed continuously and categorically (in quintiles: Q1–Q5) for associations with log(10) ACR and ACR risk groups. RESULTS: Greater log(10) ACR was associated with narrower vessel calibres and greater tortuosity. The high-risk group was more likely to have extended zone vessel calibres in the lowest quintile (arteriolar Q1 vs Q2–Q5: OR 1.67 [95% CI 1.17, 2.38] and venular OR 1.39 [0.98, 1.99]) and tortuosity in the highest quintile (Q5 vs Q1–Q4: arteriolar OR 2.05 [1.44, 2.92] and venular OR 2.38 [1.67, 3.40]). The effects of retinal vascular calibres and tortuosity were additive such that the participants with the narrowest and most tortuous vessels were more likely to be in the high-risk group (OR 3.32 [1.84, 5.96]). These effects were independent of duration, blood pressure, BMI and blood glucose control. CONCLUSIONS/INTERPRETATION: Higher ACR in adolescents is associated with narrower and more tortuous retinal vessels. Therefore, RVG phenotypes may serve to identify populations at high risk of diabetes complications during adolescence and well before onset of clinical diabetes complications.
format Online
Article
Text
id pubmed-6447498
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-64474982019-04-17 The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes Benitez-Aguirre, Paul Z. Wong, Tien Y. Craig, Maria E. Davis, Elizabeth A. Cotterill, Andrew Couper, Jennifer J. Cameron, Fergus J. Mahmud, Farid H. Jones, Tim W. Hodgson, Lauren A. B. Dalton, R. Neil Dunger, David B. Donaghue, Kim C. Diabetologia Article AIMS/HYPOTHESIS: We examined the hypothesis that elevation in urinary albumin creatinine ratio (ACR) in adolescents with type 1 diabetes is associated with abnormal retinal vascular geometry (RVG) phenotypes. METHODS: A cross-sectional study at baseline of the relationship between ACR within the normoalbuminuric range and RVG in 963 adolescents aged 14.4 ± 1.6 years with type 1 diabetes (median duration 6.5 years) screened for participation in AdDIT. A validated algorithm was used to categorise log(10) ACR into tertiles: upper tertile ACR was defined as ‘high-risk’ for future albuminuria and the lower two tertiles were deemed ‘low-risk’. RVG analysis, using a semi-automated computer program, determined retinal vascular calibres (standard and extended zones) and tortuosity. RVG measures were analysed continuously and categorically (in quintiles: Q1–Q5) for associations with log(10) ACR and ACR risk groups. RESULTS: Greater log(10) ACR was associated with narrower vessel calibres and greater tortuosity. The high-risk group was more likely to have extended zone vessel calibres in the lowest quintile (arteriolar Q1 vs Q2–Q5: OR 1.67 [95% CI 1.17, 2.38] and venular OR 1.39 [0.98, 1.99]) and tortuosity in the highest quintile (Q5 vs Q1–Q4: arteriolar OR 2.05 [1.44, 2.92] and venular OR 2.38 [1.67, 3.40]). The effects of retinal vascular calibres and tortuosity were additive such that the participants with the narrowest and most tortuous vessels were more likely to be in the high-risk group (OR 3.32 [1.84, 5.96]). These effects were independent of duration, blood pressure, BMI and blood glucose control. CONCLUSIONS/INTERPRETATION: Higher ACR in adolescents is associated with narrower and more tortuous retinal vessels. Therefore, RVG phenotypes may serve to identify populations at high risk of diabetes complications during adolescence and well before onset of clinical diabetes complications. Springer Berlin Heidelberg 2018-02-02 2018 /pmc/articles/PMC6447498/ /pubmed/29396691 http://dx.doi.org/10.1007/s00125-017-4538-2 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Benitez-Aguirre, Paul Z.
Wong, Tien Y.
Craig, Maria E.
Davis, Elizabeth A.
Cotterill, Andrew
Couper, Jennifer J.
Cameron, Fergus J.
Mahmud, Farid H.
Jones, Tim W.
Hodgson, Lauren A. B.
Dalton, R. Neil
Dunger, David B.
Donaghue, Kim C.
The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes
title The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes
title_full The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes
title_fullStr The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes
title_full_unstemmed The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes
title_short The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes
title_sort adolescent cardio-renal intervention trial (addit): retinal vascular geometry and renal function in adolescents with type 1 diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447498/
https://www.ncbi.nlm.nih.gov/pubmed/29396691
http://dx.doi.org/10.1007/s00125-017-4538-2
work_keys_str_mv AT benitezaguirrepaulz theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT wongtieny theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT craigmariae theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT daviselizabetha theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT cotterillandrew theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT couperjenniferj theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT cameronfergusj theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT mahmudfaridh theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT jonestimw theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT hodgsonlaurenab theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT daltonrneil theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT dungerdavidb theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT donaghuekimc theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT benitezaguirrepaulz adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT wongtieny adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT craigmariae adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT daviselizabetha adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT cotterillandrew adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT couperjenniferj adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT cameronfergusj adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT mahmudfaridh adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT jonestimw adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT hodgsonlaurenab adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT daltonrneil adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT dungerdavidb adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT donaghuekimc adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes
AT adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes